Rocket Pharmaceuticals (RCKT) Stock Price, Quote, News & History | Benzinga

Rocket Pharmaceuticals Inc (RCKT) Stock Price, Quote, News & History

RCKTNASDAQ

Trade with Public

Trade with Public

$3.51

0.030.86%

At close: Aug 21, 5:00 PM EST

$3.51

N/A

After Hours: Aug 21, 4:15 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.52

Close

$3.51

Volume / Avg.

939.79K / 2.25M

Day Range

$3.48 - $3.61

52 Wk Range

2.53 - 5.45

Market Cap

$385.31M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

52

Short Interest

17.3%

Days to Cover

11.9

Recent Rocket Pharmaceuticals, Inc. News

Rocket Pharmaceuticals Touts Positive Early Safety Data from Revised Genetic Therapy Trial

Rocket Pharmaceuticals announces positive early safety results for its RP-A501 Phase 2 trial in Danon disease and plans further FDA talks.

Vandana Singh

Expedia To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Monday

Top analysts changed ratings for OVV, ALMS, CLMT, LGN, RCKT, UTHR, VNT, HOOD. See full changes at benzinga.com/analyst-stock-ratings

Avi Kapoor

Why Is Rocket Pharma Stock Soaring Friday?

Rocket Pharmaceuticals stock jumps after FDA nod for Kresladi in LAD-I; voucher sale may boost cash runway and support growth plans.

Vandana Singh

Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy

William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-170.27M

Investing Cash Flow (TTM)

361.85M

Financing Cash Flow (TTM)

82.00K

Free Cash Flow (TTM)

-170.39M

Capital Expenditure (TTM)

-127.00K

Net Change in Cash (TTM)

191.66M

Analyst Trends and Forecast

1

Feb

2

1

Mar

1

May

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$125.81M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.03

Earnings Yield % (TTM)

-4.89%

Earnings Yield % (FWD)

-6.04%

EV / EBITDA (TTM)

41.27

Price / EBITDA (TTM)

132.27

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.36

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$224.51M

Debt to Equity

0.07

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$3.52

Close

$3.51

Volume / Avg.

939.79K / 2.25M

Day Range

$3.48 - $3.61

52 Wk Range

2.53 - 5.45

Market Cap

$385.31M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

52

Short Interest

17.3%

Days to Cover

11.9

About

Sector

Health Care

Industry

Biotechnology

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Rocket Pharmaceuticals (RCKT) stock?

A

You can purchase shares of Rocket Pharmaceuticals (NASDAQ:RCKT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Rocket Pharmaceuticals (RCKT) competitors?

A

Other companies in Rocket Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Rocket Pharmaceuticals (RCKT) stock?

A

Rocket Pharmaceuticals has a consensus price target of $32.17.

Q

What is the current price for Rocket Pharmaceuticals (RCKT)?

A

The stock price for Rocket Pharmaceuticals (NASDAQ: RCKT) is $3.51 last updated August 21, 2026 at 4:15 PM EDT.

Q

Does Rocket Pharmaceuticals (RCKT) pay a dividend?

A

There are no upcoming dividends for Rocket Pharmaceuticals.

Q

When is Rocket Pharmaceuticals (NASDAQ:RCKT) reporting earnings?

A

Rocket Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Rocket Pharmaceuticals (RCKT) going to split?

A

There is no upcoming split for Rocket Pharmaceuticals.

Q

What sector and industry does Rocket Pharmaceuticals (RCKT) operate in?

A

Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.